Black checkmark with a sparkle and a curved line underneath on a white background.
Company

Elite Health Systems Inc.

Ticker
EHSI
Sector
Industry
Report date
May 21, 2026
Valye AI Score

100

Very high visibility
Recent developments
Recent developments summary

Recent news items are unrelated to Elite Health Systems Inc. and do not provide direct information about the company’s business or financial condition.

Recent developments:
  • No recent business-specific news coverage was identified for Elite Health Systems Inc. in the provided recent news dataset [N1][N2][N3][N4][N5][N6][N7][N8].
Overview

Elite Health Systems Inc. is a healthcare company focused on operating managed care organizations through its subsidiary Elite Health Plan, Inc. The company offers Medicare Advantage plans targeting seniors, primarily in California counties such as San Bernardino, Los Angeles, and Riverside. It holds a contract with CMS as a Medicare Advantage organization, with enrollment dependent on annual contract renewal. The company launched its Medicare Advantage plans on January 1, 2026, and began onboarding members in late 2025. Elite Health Systems has a limited operating history and has incurred net losses due to start-up costs, acquisitions, and operational expenses. It funds its operations primarily through private placements of common stock and has raised approximately $14 million in gross proceeds through 2025 and early 2026. The company faces liquidity challenges and has expressed substantial doubt about its ability to continue as a going concern without additional capital.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Elite Health Systems Inc. operates a managed care organization through its subsidiary Elite Health Plan, offering Medicare Advantage plans primarily in California. The company launched its plans in early 2026 and has no revenue yet, incurring net losses and significant expenses related to plan operations and acquisitions. It funds operations through private stock placements and faces liquidity challenges with substantial doubt about its ability to continue as a going concern. Key risks include execution of its Medicare Advantage strategy, licensing, enrollment growth, capital raising, and liquidity management [S2][S12][S13].

Scenarios for EHSI

Bull case model:

The company has secured CMS contracts and launched Medicare Advantage plans, positioning it to serve a growing senior population in California. It has raised capital through private placements to support operations and acquisitions, including PSS, which may enhance its capabilities. Successful execution of its managed care strategy and expansion of enrollment could improve its financial position and operational scale.

Bear case model:

Elite Health Systems faces significant execution risks including uncertainties in obtaining and maintaining Medicare Advantage licenses, expanding consumer enrollment, and integrating acquisitions. The company has no revenue as of the latest quarter and has incurred substantial net losses. Liquidity constraints and lack of access to credit raise substantial doubt about its ability to continue as a going concern. Failure to raise additional capital or manage costs could impair its business and financial condition.

Moat:

Elite Health Systems operates in the managed care sector with a focus on Medicare Advantage plans, a highly regulated and competitive market. Its moat is limited due to its recent market entry, limited operating history, and dependence on regulatory approvals and annual CMS contract renewals. The company’s ability to scale and maintain licenses, expand enrollment, and manage costs will be critical to establishing competitive advantages. Its moat is currently constrained by execution risks and capital requirements inherent in the healthcare insurance industry.

Risks overview
Risks summary
The most significant risks for Elite Health Systems relate to execution of its Medicare Advantage strategy, licensing and regulatory approvals, capital raising and liquidity constraints, and operational integration challenges.
Risks details:

• Execution Risk in Medicare Advantage Strategy: Uncertainties exist regarding the company's ability to successfully implement its strategy of developing Medicare Advantage plans under its Elite Health subsidiaries.
• Licensing and Regulatory Risk: There is uncertainty over the company's ability to obtain and maintain Medicare Advantage licenses in California and potentially other states, which is critical for its operations.
• Capital Raising and Liquidity Risk: The company faces challenges in raising capital on satisfactory terms and has limited liquidity, with substantial doubt about its ability to continue as a going concern without additional funding.
• Operational and Integration Risk: Risks include the ability to integrate acquisitions such as PSS and manage costs, systems, and growth effectively.
• Competitive and Market Risk: The company operates in a highly competitive and rapidly changing environment, dependent on achieving profitability, increasing revenues, maintaining partnerships, and protecting intellectual property.

FINAL FORECAST FOR EHSI

Final take one line
Elite Health Systems Inc. operates Medicare Advantage plans with limited operating history, facing execution and liquidity risks amid ongoing capital needs.
Final take 12 to 24 month view

Business trends: The company is focused on establishing and expanding Medicare Advantage plans primarily in California, with recent launch and onboarding activities.
Execution milestones: Key milestones include maintaining CMS contracts, expanding enrollment, integrating acquisitions like PSS, and securing additional capital.
Key risks: Execution uncertainties, licensing and regulatory approvals, capital raising challenges, liquidity constraints, and competitive pressures.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

100
LLM visibility overview
LLM Visibility known facts
  • Elite Health Systems Inc. operates through its wholly owned subsidiary Elite Health Plan, Inc. (EHP), which is a managed care organization operating Medicare Advantage plans for seniors primarily in California counties including San Bernardino, Los Angeles, and Riverside [S2][S17].
  • EHP holds a contract with the Centers for Medicare and Medicaid Services (CMS) as a Medicare Advantage/Medicare Prescription Drug (MA/MA-PD) organization, with enrollment dependent on annual CMS contract renewal [S17].
  • The company launched its Medicare Advantage plans on January 1, 2026, and began onboarding members in October 2025 [S2][S17].
  • Elite Health Systems has limited operating history and had no revenue as of the latest quarter ending March 31, 2026, incurring significant expenses related to the launch and operations of its Medicare Advantage plans [S2].
  • The company acquired PSS, which contributed to increased selling, general, and administrative expenses and net losses in recent periods [S2].
  • For the quarter ended March 31, 2026, the company reported a net loss of approximately $1.3 million and a basic EPS of -$0.05, compared to a net loss of $424,000 in the prior year quarter [S2].
  • As of March 31, 2026, Elite Health Systems had cash and cash equivalents of approximately $2.6 million, current assets of $3.27 million, current liabilities of $1.36 million, resulting in a current ratio of 2.4 and a cash ratio of 1.91 [S2].
  • The company has funded operations primarily through private placements of common stock, raising approximately $14 million in gross proceeds through 2025 and early 2026, with 28,521,620 shares outstanding as of March 31, 2026 [S2][S13].
  • Management has expressed substantial doubt about the company's ability to continue as a going concern due to limited liquidity and lack of access to lines of credit or other capital sources, but believes its plans to raise additional capital and operate managed care plans may alleviate this doubt [S2][S12][S13].
  • Key risks disclosed include uncertainties in successfully implementing the Medicare Advantage strategy, obtaining and maintaining licenses, acquiring and expanding consumer enrollment, integrating acquisitions, raising capital on satisfactory terms, and managing liquidity and growth [S2][S4].
  • The company operates in a highly competitive and rapidly changing environment, dependent on achieving profitability, increasing revenues, maintaining partnerships, and protecting intellectual property [S5].
Sources
Sources - Context summary

Generated 2026-05-21

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-04-15 | 10-K
  • S2 | 2026-05-20 | 10-Q
Sources - News headlines
  • N1 | 2026-05-21 | www.nasdaq.com | AMD Begins Production Ramp Of Venice In Taiwan; Plans To Ramp At TSMC Arizona | https://www.nasdaq.com/articles/amd-begins-production-ramp-venice-taiwan-plans-ramp-tsmc-arizona
  • N2 | 2026-05-21 | www.nasdaq.com | Is Target Corp a Buy After Its Latest Earnings Report? | https://www.nasdaq.com/articles/target-corp-buy-after-its-latest-earnings-report
  • N3 | 2026-05-21 | www.nasdaq.com | Bougainville Copper Appoints Sir Melchior Togolo As CEO | https://www.nasdaq.com/articles/bougainville-copper-appoints-sir-melchior-togolo-ceo
  • N4 | 2026-05-21 | www.nasdaq.com | Wheat Posts Losses on Wednesday | https://www.nasdaq.com/articles/wheat-posts-losses-wednesday
  • N5 | 2026-05-21 | www.nasdaq.com | Is Nvidia a Buy After Their Latest Earnings Report? | https://www.nasdaq.com/articles/nvidia-buy-after-their-latest-earnings-report
  • N6 | 2026-05-21 | www.nasdaq.com | Australian Market Extends Early Sharp Gains In Mid-market | https://www.nasdaq.com/articles/australian-market-extends-early-sharp-gains-mid-market
  • N7 | 2026-05-21 | www.nasdaq.com | Cocoa Prices Consolidate Recent Losses | https://www.nasdaq.com/articles/cocoa-prices-consolidate-recent-losses-2
  • N8 | 2026-05-21 | www.nasdaq.com | Relay Therapeutics Prices $275 Mln Offering Of Shares At $12 Per Share | https://www.nasdaq.com/articles/relay-therapeutics-prices-275-mln-offering-shares-12-share
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine